X
No Ads. No Trackers. No Kidding! (Learn More)
Loading...
Tags:
Jim Cramer weighs in on Regeneron's emergency use authorization from the FDA. [Read More]
REGN stock is shifting the market today thanks to news its coronavirus treatment received emergency FDA approval. [Read More]
Thumbnail
Covid-19 patients hoping to avoid the hospital now have a second antibody treatment available to them. [Read More]
With production help from Roche Holding, Regeneron plans to have doses for 80,000 patients ready by the end of November. ... [Read More]
The FDA approved another monoclonal antibody drug for coronavirus therapy — this time it's Regeneron's dual antibody cocktail. Casirivimab and imdevimab received an Emergency Use... [Read More]
Thumbnail
Jim Cramer and Katherine Ross are going live to discuss AstraZeneca, Regeneron, Tesla and other stocks Monday, Nov. 23. [Read More]
News from AstraZeneca gave major indexes a boost Monday morning. Here's what's moving. [Read More]
Text size ... [Read More]
U.S. stock futures rose on news of a promising Covid-19 vaccine trial. [Read More]
The stocks making the biggest moves in premarket trading include Merck, Korn Ferry, Regeneron, and more. [Read More]
On Today's Hard Factor News...- BIG Covid Update, whats going on with closings, Regeneron, vaccine, and who China is blaming for the whole pandemic.- America's... [Read More]
Regeneron said its COIVD cocktail therapy, used in the treatment of President Donald Trump, has received Emergency Use Authorization from the Food & Drug Administration. [Read More]
On Monday, AstraZeneca announced that its experimental coronavirus — which was developed in conjunction with U.K.'s University of Oxford — vaccine has shown an average... [Read More]
Stock futures rise on further progress on the development of a coronavirus vaccine; AstraZeneca's vaccine found to be as much as 90% effective in preventing... [Read More]
The FDA issued an emergency use authorization to Regeneron for its covid-19 monoclonal antibody cocktail, which is made up of casirivimab and imdevimab, citing a... [Read More]
The Food and Drug Administration issued an emergency use authorization over the weekend for an antibody therapy by Regeneron Pharmaceuticals. [Read More]
A new treatment could be on the table if you contract COVID-19 but it won't be an option for everyone.  Regeneron's antibody cocktail called "regen-cov2"... [Read More]
The experimental cocktail from the biotech company Regeneron is the same drug President Trump got when he was battling the coronavirus this year. It is... [Read More]
Antibody drug cocktail casirivimab and imdevimab are allowed for use by people over age 12 with mild or moderate Covid-19. [Read More]
U.S. health officials Saturday agreed to allow emergency use of a second antibody drug to help the immune system fight COVID-19, an experimental medicine that... [Read More]
Loading...
Save As
Preview
Preview